These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4093908)

  • 21. Fetal alloantigen is responsible for the expansion of the CD4(+)CD25(+) regulatory T cell pool during pregnancy.
    Zhao JX; Zeng YY; Liu Y
    J Reprod Immunol; 2007 Oct; 75(2):71-81. PubMed ID: 17686527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of alloreactive cytotoxic T cells by paternal major histocompatibility antigens during murine pregnancy.
    Manjunath R; Ozato K; Mukherjee AB
    Biol Reprod; 1985 Oct; 33(3):668-78. PubMed ID: 3876851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
    Ramos A; Merino R; Merino J
    Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnant mice are not primed but can be primed to fetal alloantigens.
    Wegmann TG; Waters CA; Drell DW; Carlson GA
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2410-4. PubMed ID: 287081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity and in vivo correlates of alloantigen-specific murine suppressor T cells induced by allogeneic pregnancy.
    Nagarkatti PS; Clark DA
    J Immunol; 1983 Aug; 131(2):638-43. PubMed ID: 6223087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The transplantation biology of mammalian gestation.
    Billingham RE
    Am J Obstet Gynecol; 1971 Oct; 111(4):469-83. PubMed ID: 4398461
    [No Abstract]   [Full Text] [Related]  

  • 27. Placental immunoregulation.
    Hunziker RD; Wegmann TG
    Crit Rev Immunol; 1986; 6(3):245-85. PubMed ID: 3524999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell recognition and immunity in the fetus and mother.
    Koch CA; Platt JL
    Cell Immunol; 2007 Jul; 248(1):12-7. PubMed ID: 17920574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural mechanisms for evading graft rejection: the fetus as an allograft.
    Koch CA; Platt JL
    Springer Semin Immunopathol; 2003 Sep; 25(2):95-117. PubMed ID: 12955462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct activation of Sendai virus (HVJ)-specific cell-mediated immunity of mice for second set rejection of the virus-infected syngeneic tumor by noninfectious virus-sensitized spleen cells.
    Kamihira O; Nakashima I; Hasegawa T; Ando K; Isobe K; Nagase F; Hasegawa Y; Yoshida T; Kawashima K; Yoshida T
    Immunol Lett; 1985; 11(2):75-81. PubMed ID: 3002972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.
    Benichou G; Takizawa PA; Olson CA; McMillan M; Sercarz EE
    J Exp Med; 1992 Jan; 175(1):305-8. PubMed ID: 1730925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphological and functional studies of fetal thymus transplants in mice.
    Biggar WD; Stutman O; Good RA
    J Exp Med; 1972 Apr; 135(4):793-807. PubMed ID: 5018052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal and fetal immune responses during pregnancy.
    Sargent IL
    Exp Clin Immunogenet; 1993; 10(2):85-102. PubMed ID: 8251183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Placental MHC class I antigen expression is induced in mice following in vivo treatment with recombinant interferon-gamma.
    Mattsson R; Holmdahl R; Scheynius A; Bernadotte F; Mattsson A; Van der Meide PH
    J Reprod Immunol; 1991 Feb; 19(2):115-29. PubMed ID: 1901087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoregulation of fetal and anti-paternal immune responses.
    Seavey MM; Mosmann TR
    Immunol Res; 2008; 40(2):97-113. PubMed ID: 18213524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and stimulatory cell type requirements for inducing class I major histocompatibility complex alloantigen-specific in vivo cytotoxic T cell immunity.
    Mizoguchi K; Nakashima I; Isobe K; Ando K; Nagase F; Kato N; Kawashima K; Shimokata K; Hasegawa Y
    Eur J Immunol; 1985 May; 15(5):487-94. PubMed ID: 3873341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fetal bone grafts do not elicit allograft rejection because of protecting anti-Ia alloantibodies. Implications to the immune survival of fetuses in allogeneic mothers.
    Segal S; Siegal T; Altaraz H; Lev-El A; Nevo Z; Nebel L; Katzenelson A; Feldman M
    Transplantation; 1979 Aug; 28(2):88-95. PubMed ID: 384624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoregulatory effects of lymphokine-driven placental cells on cloned T cells in vitro.
    Mogil RJ; Wegmann TG
    Reg Immunol; 1988; 1(1):69-77. PubMed ID: 3275130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of mammalian pregnancy in the presence of the maternal immune system.
    Bainbridge DR
    Rev Reprod; 2000 May; 5(2):67-74. PubMed ID: 10864850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Enhancing antibodies and supressive cells in maternal anti-fetal immune reaction].
    Chaouat G; Voisin GA; Daëron M; Kanellopoulos J
    Ann Immunol (Paris); 1977; 128(1-2):21-4. PubMed ID: 848875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.